Clinical trial

Cardiotoxicity of Adjuvant Trastuzumab

NCT00858039

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2009-02-01

PhaseN/A

Study timeline

Study start (unknown)2009-02-01Date precision: month

Registry last updated2014-11-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Neoplasmsunresolved

Heart Failureunresolved

Interventions

Sponsors & collaborators

Royal Prince Alfred Hospital, Sydney, Australialead sponsor

Mapped research locations

SydneyNew South Wales, Australia10

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00858039 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.